SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Azenta
AZTA 30.55+1.1%Nov 5 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: robert b furman who wrote (962)9/17/2015 10:12:53 AM
From: robert b furman  Read Replies (1) of 1138
 
Brooks just keeps on making leadership new storage systems - now complete witha high growth p-chip to identify samples stored.

Pharma Seq just got put on the map with regards to life sciences and storage capabilities.

Looks like an exciting acquisition to make for brooks ( to me).

globenewswire.com

HELMSFORD, Mass., Sept. 16, 2015 (GLOBE NEWSWIRE) -- Brooks Automation (NASDAQ: BRKS), a leading worldwide provider of automation and cryogenic solutions for semiconductor manufacturing and life science markets, and PharmaSeq, Inc., a provider of technology based on the ultra-small light-activated microtransponder (p-Chip®), announced today a definitive exclusive agreement to license PharmaSeq’s p-Chip technology for use in life sciences applications. The emphasis will be on tagging and tracking biological and related samples used in biorepositories, including cryogenic storage and related areas. In addition to obtaining the exclusive license, Brooks has agreed to make an equity investment in PharmaSeq and the Companies plan to cooperate on future technology developments.

Under the agreement, PharmaSeq will supply p-Chips and related components to Brooks who will incorporate them into a new, advanced line of biosample storage systems. The initial offerings will include sample tubes tagged with p-Chips, readers, and robotic storage devices that will provide Brooks’ customers with integrated systems for managing large quantities of samples.

Dusty Tenney, President of Brooks Life Sciences stated, “The agreement with PharmaSeq is an important step in expanding our capabilities within life sciences. The p-Chip technology further enables reliable information and security for samples in challenging cold conditions down to low cryogenic (-190°C) temperatures and is compatible with our range of biostorage products, including our newest release, the BioStore III Cryo automated -150°C store.”

Richard G. Morris, Ph.D., CEO of PharmaSeq, remarked, “This is a key milestone for PharmaSeq. Our business strategy involves licensing our technology to industry leaders who will rapidly bring new products to customers through their existing distribution channels. Brooks is a company widely admired for its engineering expertise in automated storage systems as well as its world-class sales and distribution organization. We are delighted that our p-Chip is expected to be an important component in Brooks’ product offering. We are confident that Brooks will establish p-Chip-containing products as a new industry standard to be widely adopted by the biobanking and biopharma industry.”

- See more at: globenewswire.com

Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext